Understanding OUR Cytokine-Based Immunotherapy Candidates Our commitment extends to advancing a robust portfolio of programs geared toward growing the horizons of cytokine-based immunotherapy, especially for cancers where therapy alternatives remain limited. Use the links below to learn additional about our portfolio of cytokine-based immunotherapy candidates. Check out Our Pipeline https://financefeeds.com/best-copyright-in-2025-top-8-moonshot-projects-to-watch/